Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

PAXLOVID

News, A to Z Feature 19/03/2025

A to Z: Drugs in Highlight: P is for PAXLOVID®

Secerna Website Images 2025 (8)

News, Team news, Careers 19/03/2025

Join Our Growing Team: Part-Qualified Patent Attorney, Physics & Engineering

Trademark Canva

Industry news, News 18/03/2025

Global IP Filings Show Strengthening: WIPO Report Signals Innovation Growth

Ozempic (1)

News, A to Z Feature 13/03/2025

A to Z: Drugs in Highlight: O is for OZEMPIC®

Patent Box Update 2025 (2)

Industry news, News 10/03/2025

Unlocking Innovation: The Latest on the UK Patent Box Scheme

NILEMDO

News, A to Z Feature 07/03/2025

A to Z: Drugs in Highlight: N is for NILEMDO®

Nepic Jason And Melvyn

Events, Team news 06/03/2025

Secerna attending NEPIC Cluster Connect 2025

Jason And Jacob

Industry news, News, Team news 04/03/2025

Secerna Expands Physics Team with New Trainee Patent Attorney

Sam

News, Team news, Careers 04/03/2025

Learn about life as a Trade Mark Attorney

1 2 3 4 5 6 7 8